Equities

CorVel Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CRVL:NSQ

CorVel Corp

Actions
Health CareHealth Care Providers
  • Price (USD)49.50
  • Today's Change0.300 / 0.61%
  • Shares traded279.81k
  • 1 Year change-57.81%
  • Beta1.1234
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

  • Revenue in USD (TTM)941.49m
  • Net income in USD105.73m
  • Incorporated1991
  • Employees5.08k
  • Location
    CorVel Corp5128 Apache Plume Road, Suite 400FORT WORTH 76109United StatesUSA
  • Phone+1 (817) 390-1416
  • Fax+1 (949) 851-1469
  • Websitehttps://www.corvel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ardent Health Inc6.33bn205.06m1.37bn19.20k6.601.113.060.21731.451.4544.838.651.2723.158.82329,455.705.96--8.08--57.94--4.69--1.957.420.404--10.29--290.22------
NeoGenomics, Inc.709.16m-113.47m1.47bn2.20k--1.75--2.08-0.8877-0.88775.556.500.470315.154.62322,346.40-7.52-4.23-8.66-4.5543.4640.72-16.00-11.713.62--0.2894--11.6510.0710.51--15.44--
Acadia Healthcare Company Inc3.27bn107.36m1.55bn19.19k14.220.4865.130.47381.181.1835.7934.500.5317--8.02170,151.501.943.142.193.65----3.646.721.433.390.4125--7.699.451,279.7337.4524.30--
Aveanna Healthcare Holdings Inc2.29bn75.46m1.66bn3.50k21.56167.1019.330.72330.36780.367811.010.04751.33--7.69654,454.604.37-10.765.72-13.0033.5731.323.29-11.05--1.830.9933--6.827.9091.88---17.60--
Progyny Inc1.27bn56.57m1.78bn675.0033.123.1829.231.410.62460.624613.956.501.74--4.761,879,539.007.7711.3110.9215.5422.9421.654.466.66----0.000.007.2238.42-12.41--12.83--
Pediatrix Medical Group Inc1.92bn162.19m1.85bn2.15k11.302.079.980.96131.901.9022.6010.380.8991--7.42894,159.107.590.01089.240.0129----8.440.0155--14.610.40350.000.91642.49-64.00--2.71--
Surgery Partners Inc3.29bn-171.40m2.00bn15.00k--1.1511.540.6081-1.36-1.3625.9413.410.424827.715.86219,206.700.3010.97260.42971.3626.5726.230.70862.461.722.290.5007--13.5211.20-1,312.61--4.20--
Select Medical Holdings Corp4.06bn-34.63m2.03bn30.00k--1.2012.390.50-0.25920.920532.7113.640.5927--4.30135,206.500.20213.000.25643.8511.9212.700.3414.19--2.250.467332.737.48-0.998210.99-15.137.17--
Addus Homecare Corporation1.35bn85.65m2.10bn6.17k24.372.0020.801.564.674.6773.4356.811.05--11.68218,426.006.655.397.586.2532.6631.716.365.43--12.660.12550.009.0612.2217.7323.315.54--
CorVel Corp941.49m105.73m2.52bn5.08k24.106.7018.392.672.042.0418.187.351.59--9.04185,515.9017.8716.1629.5226.6624.2222.6011.239.71----0.000.0012.618.6224.8014.972.02--
GeneDx Holdings Corp402.19m2.08m2.61bn1.00k1,455.688.9179.506.480.06190.061914.0510.120.89111.448.11402,190.000.4615-62.350.5647-78.9069.6520.780.5179-111.422.594.050.153--50.799.2670.25---18.70--
National Healthcare Corp1.50bn101.25m2.63bn14.96k26.182.5017.781.756.486.4896.0367.870.9574117.5911.49100,295.306.605.457.976.6138.5539.296.896.541.72--0.064646.4314.535.5852.598.360.8933.30
Lifestance Health Group Inc1.37bn-9.12m2.73bn8.00k--1.8358.342.00-0.0239-0.02393.543.840.6425--9.80133,839.30-0.4283-8.96-0.4785-9.73-----0.6667-19.11--0.56840.1589--18.5042.5569.16--8.54--
Privia Health Group Inc2.04bn18.17m2.75bn1.14k157.543.8881.911.350.14210.142115.995.771.64--4.501,791,727.001.96-3.813.68-6.2710.179.481.20-2.05----0.00--4.7417.17-37.6711.78----
Concentra Group Holdings Parent Inc2.09bn151.68m3.02bn8.76k11.567.8313.081.442.042.0420.683.010.7848--8.17238,567.905.99--6.79--28.36--7.63----3.070.7972--3.38---7.45------
Data as of Feb 17 2026. Currency figures normalised to CorVel Corp's reporting currency: US Dollar USD

Institutional shareholders

35.98%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 31 Dec 20254.99m9.74%
BlackRock Fund Advisorsas of 31 Dec 20254.21m8.21%
The Vanguard Group, Inc.as of 31 Dec 20252.99m5.83%
Renaissance Technologies LLCas of 31 Dec 20251.69m3.29%
SSgA Funds Management, Inc.as of 31 Dec 20251.18m2.30%
Dimensional Fund Advisors LPas of 31 Dec 20251.16m2.26%
Geode Capital Management LLCas of 31 Dec 2025927.85k1.81%
Boston Trust Walden, Inc.as of 31 Dec 2025494.15k0.96%
Norges Bank Investment Managementas of 31 Dec 2025432.25k0.84%
Silvercross Investment Management BVas of 31 Jul 2025375.17k0.73%
More ▼
Data from 31 Jul 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.